March 16, 2020 / 10:38 PM / in 18 days

BRIEF-American Renal Associates Reports Q4 Adjusted EPS Of $0.19

March 16 (Reuters) - American Renal Associates Holdings Inc :

* AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES FOURTH QUARTER 2019 RESULTS

* COMPANY ANNOUNCES CEO PLANS TO RETIRE BY END OF 2020

* BOARD WILL INITIATE A PROCESS TO IDENTIFY A SUCCESSOR FOR CARLUCCI

* JOSEPH CARLUCCI HAS COMMUNICATED HIS INTENTION TO RETIRE AS CEO

* CARLUCCI PLANS TO CONTINUE AS CEO AND CHAIRMAN UNTIL HIS SUCCESSOR HAS STARTED

* QTRLY PATIENT SERVICE OPERATING REVENUES WERE $206.1 MILLION, A DECREASE OF 0.8%

* EXPECTS 2020 NORMALIZED TOTAL TREATMENT GROWTH TO BE IN A RANGE OF 4.5% AND 5.0%

* EXPECTS 2020 ADJUSTED EBITDA-NCI TO BE IN A RANGE OF $90 MILLION AND $95 MILLION

* 2020 ADJUSTED EBITDA-NCI OUTLOOK EXCLUDES ANY POTENTIAL IMPACT FROM COVID-19 OUTBREAK

* QTRLY LOSS PER SHARE $0.22 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below